Coding
and Billing
Coding and billing information for Rapivab® (peramivir injection)
Use this information to facilitate coding and billing processes. Some payers will require the National Drug Code (NDC) code for Rapivab.1
Support and access for Rapivab
RAPIVAB CUSTOMER SUPPORT CENTER
1-833-964-2956 and rapivab.com
-
Current Procedural Terminology (CPT) Codes for Rapivab
The following CPT codes are for treatments administered via injection to individuals.
CPT Code 2 Description 96365 Intravenous (IV) infusion for therapy, prophylaxis, or diagnosis; initial, up to first hour 96366 IV med therapy−each additional hour 96374 IV med injection−first med 96375 IV med injection−second med subsequent injection 96376 IV med injection−first med subsequent injection 96360 IV hydration−first hour 96361 IV hydration−each additional hour HCPCS Code 3 Description J2547 Injection, peramivir, 1 mg - Report the administration of Rapivab in addition to the treatment product code
- Assign the appropriate administration code based on the documentation in the medical record
- Medicare requires the use of an HCPCS code for the administration of Rapivab. Some payers may also require that an HCPCS code be used to report Rapivab
Prior authorizations or appeals may not be completed or filed on the HCP's behalf.
-
Revenue codes for Rapivab
These codes are used to attribute hospital charges to specific cost centers. They may vary by service provided and patient status.
Revenue Code 4 Description 0636 Drugs requiring detailed coding required by Medicare to obtain pass-through payment for drugs in the outpatient department 0250 Pharmacy, general 0260 Intravenous therapy, general 0450 Emergency room 0510 Clinic 0520 IV hydration–first hour -
ICD-10-CM codesa for Rapivab
Refer to these tables when you need the ICD-10-CM codes for Rapivab.
ICD-10 Code 5 Description J10.00 Influenza due to other identified influenza virus with unspecified type of pneumonia J10.01 Influenza due to other identified influenza virus with the same other identified influenza virus pneumonia J10.08 Influenza due to other identified influenza virus with other specified pneumonia J11.00 Influenza due to unidentified influenza virus with unspecified type of pneumonia J11.08 Influenza due to unidentified influenza virus with specified pneumonia J12.9 Viral pneumonia, unspecified J10.1 Influenza due to other identified influenza virus with other respiratory manifestations J11.1 Influenza due to unidentified influenza virus with other respiratory manifestations J10.2 Influenza due to other identified influenza virus with gastrointestinal manifestations J10.81 Influenza due to other identified influenza virus with encephalopathy J10.82 Influenza due to other identified influenza virus with myocarditis J10.83 Influenza due to other identified influenza virus with otitis J10.89 Influenza due to other identified influenza virus with other manifestations J11.2 Influenza due to unidentified influenza virus with gastrointestinal manifestations J11.81 Influenza due to unidentified influenza virus with encephalopathy J11.82 Influenza due to unidentified influenza virus with myocarditis J11.83 Influenza due to unidentified influenza virus with otitis media J11.89 Influenza due to unidentified influenza virus with other manifestations J09.X1 Influenza due to identified novel influenza A virus with pneumonia J09.X2 Influenza due to identified novel influenza A virus with other respiratory manifestations J09.X3 Influenza due to identified novel influenza A virus with gastrointestinal manifestations J09.X9 Influenza due to identified novel influenza A virus with other manifestations aThis may not be an all-inclusive list; see payor-specific coverage policies for covered indication.